Skip to main content
Midas Edge

TRINITY BIOTECH PLC

For the period ended Sep 8, 2026. Filed Sep 8, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Sep 8, 2026 · Filed Sep 8, 2026

Use the contents to explore the available documents and sections.

TRIB$5.70-3.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EXPLANATORY NOTE

A copy of the Trinity Biotech plc Annual Report 2025 is furnished herewith as Exhibit 99.1.

Trinity Biotech plc sent holders of its Ordinary Shares the following: “Letter from the Company Secretary of Trinity Biotech plc“, “Notice of Annual General Meeting“ and “Form of Proxy“. Copies of these documents are filed herewith as Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4 and incorporated herein by reference.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.